Zanamivir oral delivery: enhanced plasma and lung bioavailability in rats

about

Zanamivir oral delivery: enhanced plasma and lung bioavailability in rats

Item

http://www.wikidata.org/entity/Q37145564

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on March 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Zanamivir oral delivery: enhanced plasma and lung bioavailability in rats

@en

Zanamivir oral delivery: enhanced plasma and lung bioavailability in rats.

@nl

type

Item

label

Zanamivir oral delivery: enhanced plasma and lung bioavailability in rats

@en

Zanamivir oral delivery: enhanced plasma and lung bioavailability in rats.

@nl

prefLabel

Zanamivir oral delivery: enhanced plasma and lung bioavailability in rats

@en

Zanamivir oral delivery: enhanced plasma and lung bioavailability in rats.

@nl

P1476

Zanamivir oral delivery: enhanced plasma and lung bioavailability in rats

@en

P2093

Chul Soon Yong

http://www.w3.org/2001/XMLSchema#string

Han-Gon Choi

http://www.w3.org/2001/XMLSchema#string

Ho Taek Im

http://www.w3.org/2001/XMLSchema#string

Jong Oh Kim

http://www.w3.org/2001/XMLSchema#string

Jong Soo Woo

http://www.w3.org/2001/XMLSchema#string

Kyung Soo Kim

http://www.w3.org/2001/XMLSchema#string

Yong-Il Kim

http://www.w3.org/2001/XMLSchema#string

Young Taek Sohn

http://www.w3.org/2001/XMLSchema#string

P2860

Antiviral oseltamivir is not removed or degraded in normal sewage water treatment: implications for development of resistance by influenza A virus

The war against influenza: discovery and development of sialidase inhibitors

Zanamivir: from drug design to the clinic

Oseltamivir resistance during treatment of influenza A (H5N1) infection

Neuraminidase inhibitor resistance after oseltamivir treatment of acute influenza A and B in children.

Safety and efficacy of intravenous zanamivir in preventing experimental human influenza A virus infection.

Avian flu: isolation of drug-resistant H5N1 virus.

Absorption enhancement in intestinal epithelial Caco-2 monolayers by sodium caprate: assessment of molecular weight dependence and demonstration of transport routes.

Zanamivir: a review of clinical safety.

Zanamivir: a review of its use in influenza.

P304

161-169

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4062/BIOMOLTHER.2013.010

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Srinivasan Shanmugam

P577

2013-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

256452983

http://www.w3.org/2001/XMLSchema#string

P698

24009875

http://www.w3.org/2001/XMLSchema#string

P932

3762309

http://www.w3.org/2001/XMLSchema#string